The GLP is committed to full transparency. Download and review our Annual Report.

Facing escalating legal costs defending Monsanto’s Roundup, Bayer invests $5.6 billion in alternative herbicide research

Germany’s Bayer sought to repair its reputation on [June 14] after damage caused by U.S. litigation over claims its glyphosate pesticide causes cancer, saying it would invest 5 billion euros ($5.6 billion) in weedkiller research.

Bayer’s shares hit seven-year lows after a California couple was [in May] awarded more than $2 billion in the largest-ever U.S. jury award over claims that glyphosate-based weedkiller Roundup, which the German life sciences group acquired when it took over Monsanto, causes cancer.

As well as saying it would invest 5 billion euros in research over the next ten years, Bayer promised to reduce its environmental impact by 30% through 2030 via measures such as more precise and more sparing application of crop chemicals.

Related article:  Viewpoint: EU's new pesticide oversight committee is poised to further politicize glyphosate controversy

Read full, original article: Bayer to invest $5.6 billion in weedkiller research to help reputation

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend